30 Day Psychedelic Pharmacology Podcast - Day 24 Neuroinflammation and Immunity

from Cannabinoid and Psychedelic Pharmacology and Drug Development

This podcast episode explores the fascinating relationship between psychedelics and neuroinflammation, focusing on how these substances interact with the brain's immune system. The discussion delves into the role of the serotonin 5HT2A receptor and microglia in regulating inflammation, and how psychedelics might help treat conditions like depression and neurodegenerative disorders. The episode also compares psychedelics with traditional anti-inflammatory drugs and examines the therapeutic process, accessibility challenges, and future potential of psychedelic medicine.

NOW PLAYING

0:00 17:47

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Cannabinoid and Psychedelic Pharmacology and Drug Development?

This episode is 17 minutes long.

When was this Cannabinoid and Psychedelic Pharmacology and Drug Development episode published?

This episode was published on January 30, 2025.

What is this episode about?

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Cannabinoid and Psychedelic Pharmacology and Drug Development episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!